SpaceX OpenAI Anthropic IPO Valuations Could Rival Berkshire Hathaway Polymarket Traders Suggest HFCL Shares Surge 9 to AllTime High on 135 Crore RailTel Order Stock Up 160 in Under Two Months SpaceX Files for Stock Market Debut Ticker Could Be SPCX Potential to Make Elon Musk a Trillionaire Nifty Metal Index Surges 18 YTD Adding 16 Lakh Crore in Investor Wealth as Broader Market Slips Vestas Wind Systems Stock Declines After Company Warns Margins Near Guidance Floor Microns Monthly Surge Echoes 1987 Rally Analysts Flag Potential Value Opportunity LKQ Q1 2026 Earnings EPS Misses Estimates by 245 as Stock Edges Higher AVAL Q2 2025 Earnings Strong EPS Performance Drives Stock Gain NBHC Q1 2026 Earnings Earnings Miss Weighs on Investor Sentiment Despite Resilient Operations KALV Q1 2026 Earnings Narrower Loss Beats Expectations Clinical Pipeline Progress Underway Mesabi Trust MSB Q1 2026 Earnings Modest EPS of 021 Amid Flat Revenue and Stock Decline AWI Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Challenges Yuanbao Inc YB Slumps 885 as Selling Pressure Mounts Saratoga Investment Corp Notes SAY Hold Steady Near 2523 Amid Modest Uptick Space Asset Acquisition Corp SAAQ Edges Higher Amid Quiet Trading Key Levels in Focus Palisade Bio Inc PALI Edges Higher on Modest Volume Testing Resistance Levels Catalyst Bancorp CLST Inches Higher Nears Key Resistance Level Deere Beats Fiscal Q2 Estimates on Tariff Refund Lifts Outlook as Construction Segment Offsets Farm Weakness TRNR Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Falls 1254 POET Technologies POET Declines 785 as Selling Pressure Builds Key Levels to Watch Epsilon Energy EPSN Holds Steady Near Resistance Amid Modest Decline Tri Pointe Homes TPH Holds Flat as Traders Eye Support and Resistance Levels Sinclair Inc SBGI Gains 12 Approaching Key Resistance at 1502 Steakholder Foods STKH Holds Gains as Cultivated Meat Sector Shows Resilience EnerSys ENS Slides 314 as Selling Pressure Persists Key Support in Focus Zymeworks Inc ZYME Faces Selling Pressure as Shares Dip 240 Key Levels in Focus Jazz Pharmaceuticals JAZZ Shares Dip 132 as Stock Tests Key Support Levels